| Year |
Citation |
Score |
| 2018 |
Smith NR, Swain JR, Davies PS, Gallagher AC, Parappilly MS, Beach CZ, Streeter PR, Williamson IA, Magness ST, Wong MH. Monoclonal Antibodies Reveal Dynamic Plasticity Between Lgr5- and Bmi1-Expressing Intestinal Cell Populations. Cellular and Molecular Gastroenterology and Hepatology. 6: 79-96. PMID 29928673 DOI: 10.1016/J.Jcmgh.2018.02.007 |
0.335 |
|
| 2017 |
Yan KS, Gevaert O, Zheng GXY, Anchang B, Probert CS, Larkin KA, Davies PS, Cheng ZF, Kaddis JS, Han A, Roelf K, Calderon RI, Cynn E, Hu X, Mandleywala K, ... ... Smith NR, et al. Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity. Cell Stem Cell. 21: 78-90.e6. PMID 28686870 DOI: 10.1016/J.Stem.2017.06.014 |
0.319 |
|
| 2017 |
Smith NR, Davies PS, Levin TG, Gallagher AC, Keene DR, Sengupta SK, Wieghard N, El Rassi E, Wong MH. Cell Adhesion Molecule CD166/ALCAM Functions Within the Crypt to Orchestrate Murine Intestinal Stem Cell Homeostasis. Cellular and Molecular Gastroenterology and Hepatology. 3: 389-409. PMID 28462380 DOI: 10.1016/J.Jcmgh.2016.12.010 |
0.354 |
|
| 2016 |
Smith NR, Gallagher AC, Wong MH. Defining a stem cell hierarchy in the intestine: markers, caveats and controversies. The Journal of Physiology. PMID 26864260 DOI: 10.1113/Jp271651 |
0.32 |
|
| 2015 |
Joseph J, Govek S, Darimont B, Brigham D, Aparicio A, Bischoff E, Kahraman M, Nannini M, Kaufman J, Lai A, Lee K, Oeh J, Lu N, Zhou W, Moon M, ... ... Smith N, et al. Abstract 5053: Discovery of GDC-0810 a novel, non-steroidal selective estrogen receptor degrader with robust activity in pre-clinical models of endocrine-resistant breast cancer Cancer Research. 75: 5053-5053. DOI: 10.1158/1538-7445.Am2015-5053 |
0.329 |
|
| 2015 |
Zhou W, Blake RA, Nonomiya J, Qian J, Kategaya L, Wertz I, Daemen A, O'Brien T, Sensintaffar J, Moon M, Nannini MA, Oeh J, Sampath D, Wang X, Smith N, et al. Abstract 1864: Selective estrogen receptor degrader (SERD) activity in ESR1 mutant models Cancer Research. 75: 1864-1864. DOI: 10.1158/1538-7445.Am2015-1864 |
0.317 |
|
| 2014 |
Joseph JD, Darimont B, Govek S, Brigham D, Qian J, Sensintaffar J, Shao G, Aparicio A, Kahraman M, Lai A, Lee K, Lu N, Nagasawa J, Moon M, Rix P, ... Smith N, et al. Abstract 4757: A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer Cancer Research. 74: 4757-4757. DOI: 10.1158/1538-7445.Am2014-4757 |
0.322 |
|
| 2014 |
Smith NR, Levin TG, Erickson CJ, Bubbers EJ, Abe J, Wong MH. 394 The Cancer Stem Cell Marker CD166/Alcam Regulates Signaling Pathways That Govern Intestinal Epithelial Cell Growth Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)60302-4 |
0.336 |
|
| 2013 |
Wang F, Scoville D, He XC, Mahe MM, Box A, Perry JM, Smith NR, Lei NY, Davies PS, Fuller MK, Haug JS, McClain M, Gracz AD, Ding S, Stelzner M, et al. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology. 145: 383-95.e1-21. PMID 23644405 DOI: 10.1053/J.Gastro.2013.04.050 |
0.304 |
|
| 2013 |
Joseph JD, Darimont B, Govek S, Brigham D, Aparicio A, Kahraman M, Lai A, Lee K, Lu N, Nagasawa J, Kaufman J, Moon M, Prudente R, Qian J, Sensintaffar J, ... ... Smith N, et al. Abstract A37: A novel class of selective estrogen receptor degraders display activity in pre-clinical models of ERα+ ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A37 |
0.321 |
|
| 2012 |
Smith NR, Davies PS, Silk AD, Wong MH. Epithelial and mesenchymal contribution to the niche: a safeguard for intestinal stem cell homeostasis. Gastroenterology. 143: 1426-30. PMID 23085353 DOI: 10.1053/J.Gastro.2012.10.024 |
0.338 |
|
| 2012 |
Darimont B, Lu N, Sensintaffar J, Lee K, Aparicio A, Kaufman J, Bischoff E, Rix P, Heyman R, Smith N, Hager J, Joseph J, Grillot K, Qian J, Gang S, et al. Abstract A4: A novel class of selective ERα degraders acts as full antagonists/ inverse agonists and displays efficacy in pre-clinical models of endocrine-resistant breast cancer and endometrial cancer Clinical Cancer Research. 18. DOI: 10.1158/1078-0432.Mechres-A4 |
0.309 |
|
| 2011 |
Darimont B, Govek S, Joseph J, Grillot K, Bischoff E, Aparicio A, Bonnefous C, Douglas K, Julien J, Kahraman M, Kaufman J, Lai A, Lee K, Lu N, Nagasawa J, ... ... Smith N, et al. Abstract A133: A novel class of selective estrogen receptor degraders regresses tumors in preclinical models of endocrine-resistant breast cancer. Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-11-A133 |
0.319 |
|
| Show low-probability matches. |